CDK/HDAC-IN-3
Based on 1 Customer Validation
CDK/HDAC-IN-3 is an orally active HDACs/CDKs dual inhibitor. CDK/HDAC-IN-3 has potent and selective inhibition of CDK9, CDK12, CDK13, HDAC1, HDAC2 and HDAC3 with IC50 values of 98.32 nM, 98.85 nM, 100 nM, 62.12 nM, 93.28nM and 82.87 nM. CDK/HDAC-IN-3 can be used for the acute myeloid leukemia (AML) .
For research use only. We do not sell to patients.
- Purity: 99.60%
- CAS No.: 2944087-54-9
- Formula: C24H18Cl2N6O3
- Molecular Weight:509.34
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Cell Cycle/DNA Damage Compound Library
HY-L004
-
Epigenetics Compound Library
HY-L005
-
Kinase Inhibitor Library
HY-L009
-
Histone Modification Research Compound Library
HY-L024
-
Anti-Cancer Compound Library
HY-L025
-
Anti-Aging Compound Library
HY-L034
-
Reprogramming Compound Library
HY-L039
-
Oxygen Sensing Compound Library
HY-L045
-
Anti-Breast Cancer Compound Library
HY-L074
-
Anti-Pancreatic Cancer Compound Library
HY-L077
-
Anti-Blood Cancer Compound Library
HY-L079
-
Anti-Liver Cancer Compound Library
HY-L101
-
Osteogenesis Compound Library
HY-L131
-
Cancer Stem Cells Compound Library
HY-L135
-
Highly Selective Inhibitors Library
HY-L158
-
Serine/Threonine Kinase Inhibitor Library
HY-L164
-
Anti-Hematopathy Compound Library
HY-L171
-
Anti-Ovarian Cancer Compound Library
HY-L173
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
Anti-Brain Cancer Compound Library
HY-L188
-
Protein Kinase Compound Library
HY-L196
-
Cell Proliferation Compound Library
HY-L201
-
High-Throughput Bioactive Compound Library
HY-L205
-
Posttranslational Modification Library
HY-L226
-
High-Efficiency Gene Editing Compound Library
HY-L244
-
Lactylation Compound Library
HY-L249
Biological Activity
IC50: 98.32 nM (CDK9), 98.85 nM (CDK12), 100 nM (CDK13), 62.12 nM (HDAC1), 93.28nM (HDAC2) and 82.87 nM (HDAC3), 0.72 μM (U937 cell), 1.43μM (HL-60 cell), 1.63μM (SKNO-1 cell) and 0.89 μM (Kaumi-1 cell)[1].
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK-293T | IC50 |
>20 μM
Compound: 33a
|
Antiproliferative activity against HEK293T cells incubated for 72 hrs by CCK8 assay
Antiproliferative activity against HEK293T cells incubated for 72 hrs by CCK8 assay
|
[PMID: 36736154] |
| HL-60 | IC50 |
1.43 μM
Compound: 33a
|
Antiproliferative activity against human HL-60 cells incubated for 72 hrs by CCK8 assay
Antiproliferative activity against human HL-60 cells incubated for 72 hrs by CCK8 assay
|
[PMID: 36736154] |
| Kasumi 1 | IC50 |
0.89 μM
Compound: 33a
|
Antiproliferative activity against human Kasumi 1 cells incubated for 72 hrs by CCK8 assay
Antiproliferative activity against human Kasumi 1 cells incubated for 72 hrs by CCK8 assay
|
[PMID: 36736154] |
| U-937 | IC50 |
0.72 μM
Compound: 33a
|
Antiproliferative activity against human U-937 cells incubated for 72 hrs by CCK8 assay
Antiproliferative activity against human U-937 cells incubated for 72 hrs by CCK8 assay
|
[PMID: 36736154] |
CDK/HDAC-IN-3 (compound 33a) (1μM) has potent and selective inhibition of CDK9, CDK12, CDK13, HDAC1, HDAC2 and HDAC3 with IC50 values of 98.32 nM, 98.85 nM, 100 nM, 62.12 nM, 93.28nM and 82.87 nM, respectively[1].
CDK/HDAC-IN-3 (0.5 μM, 1.0 μM) significantly induces differentiation of leukemic stem-like cells and inhibits AML proliferation[1].
CDK/HDAC-IN-3 (0.5 μM, 1.0 μM, 2.0 μM) significantly induced differentiation of LSCs[1].
CDK/HDAC-IN-3 has inhibitory effect for U937, HL-60, SKNO-1 and Kaumi-1 cell with IC50 values of 0.72 μM, 1.43μM, 1.63μM and 0.89 μM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human leukemia cell lines Kaumi-1, Skno-1, HL-60 and U937
-
Concentration:At different concentrations
-
Incubation Time:72 h
-
Result:Showed strong growth inhibitory potency against AML cells.
-
Cell Line:HL-60 cell
-
Concentration:0, 30, 100, 300, 1000 nM
-
Incubation Time:6 h
-
Result:Inhibited the downstream signaling of HDAC and CDK9 in a dose-dependent manner.
-
Cell Line:HL-60 and U937 cell
-
Concentration:0.2, 0.5, 1.0, 2.0 μM
-
Incubation Time:48 h
-
Result:Induced apoptosis of AML cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley male rats (220-350 g)[1]
-
Dosage:5 mg/kg and 25 mg/kg
-
Administration:IV and PO
-
Result:
PK parameters i.v (5 mg/Kg) p.o (25 mg/Kg) Cmax(ng/L) 3644.00 1426.00 T1/2(h) 0.11 1.37 TMax(h) NA 0.75 Clearance (mL/h/kg) 5307.00 1726.00 MRT (h) 0.39 1.27 AUC (ng.h/mL) 836.00 2368.00 F% NA 56.70%
Chemical Information
-
CAS No. 2944087-54-9
-
Appearance Solid
-
Molecular Weight 509.34
-
Formula C24H18Cl2N6O3
-
Color White to yellow
-
SMILES
NC1=C(C=CC=C1)NC(C2=CC=C(C=C2)NC(C3=NNC=C3NC(C4=C(C=CC=C4Cl)Cl)=O)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
DMSO : 125 mg/mL (245.42 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9633 mL | 9.8166 mL | 19.6333 mL | 49.0831 mL |
| 5 mM | 0.3927 mL | 1.9633 mL | 3.9267 mL | 9.8166 mL | |
| 10 mM | 0.1963 mL | 0.9817 mL | 1.9633 mL | 4.9083 mL | |
| 15 mM | 0.1309 mL | 0.6544 mL | 1.3089 mL | 3.2722 mL | |
| 20 mM | 0.0982 mL | 0.4908 mL | 0.9817 mL | 2.4542 mL | |
| 25 mM | 0.0785 mL | 0.3927 mL | 0.7853 mL | 1.9633 mL | |
| 30 mM | 0.0654 mL | 0.3272 mL | 0.6544 mL | 1.6361 mL | |
| 40 mM | 0.0491 mL | 0.2454 mL | 0.4908 mL | 1.2271 mL | |
| 50 mM | 0.0393 mL | 0.1963 mL | 0.3927 mL | 0.9817 mL | |
| 60 mM | 0.0327 mL | 0.1636 mL | 0.3272 mL | 0.8181 mL | |
| 80 mM | 0.0245 mL | 0.1227 mL | 0.2454 mL | 0.6135 mL | |
| 100 mM | 0.0196 mL | 0.0982 mL | 0.1963 mL | 0.4908 mL |
Powered by Bioz